Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 13, 2003. The report details a specific corporate action regarding share re-purchases authorized by shareholders at the Annual General Meeting held on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share re-purchase transaction:
- Shares Purchased: 800,000 Ordinary 25 pence shares.
- Transaction Date: June 12, 2003.
- Price Per Share: 1,247.281 pence.
- Purpose: Purchase for cancellation.
Material Changes
The filing does not disclose material changes in operating results or financial position compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 800,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or contingencies. It is a notification of a completed transaction executed under existing shareholder authority.
Investor Verification Points
- Verify the total number of shares authorized for re-purchase at the May 19, 2003 Annual General Meeting to assess remaining capacity.
- Confirm the total cost of the transaction (800,000 shares x 1,247.281 pence) against the company's cash reserves in the most recent full financial report.
- Check subsequent filings for additional re-purchase activity under the same authorization.